Salivary IL-6 levels in oral leukoplakia with dysplasia and its clinical relevance to tobacco habits and periodontitis

Clinical Oral Investigations

Volumn 15, Issue 5, 2011, Pages 705-714

  Sharma, Mohit ^a   Bairy, Indira ^b   Pai, Keerthilatha ^a   Satyamoorthy, Kapaettu ^c   Prasad, Shailendra ^d   Berkovitz, Barry ^e   Radhakrishnan, Raghu ^a  

^a MANIPAL COLLEGE OF DENTAL SCIENCES   (India)

^b KASTURBA MEDICAL COLLEGE   (India)

^c MANIPAL UNIVERSITY   (India)

^d UNIVERSITY OF MINNESOTA   (United States)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cytokine; Epithelial dysplasia; IL 6; Leukoplakia; NF B; Oral cancer; Periodontitis; Tobacco

Indexed keywords

IL6 PROTEIN, HUMAN; INTERLEUKIN 6; SALIVA PROTEIN; TUMOR MARKER;

ADULT; AGED; ARECA; ARTICLE; COMPARATIVE STUDY; EARLY DIAGNOSIS; EPITHELIUM CELL; HUMAN; IMMUNOLOGY; LEUKOPLAKIA; MALE; MIDDLE AGED; PATHOLOGY; PERIODONTICS; PERIODONTITIS; PRECANCER; SALIVA; SMOKELESS TOBACCO; SMOKING; TOBACCO;

ADULT; AGED; ARECA; EARLY DETECTION OF CANCER; EPITHELIAL CELLS; HUMANS; INTERLEUKIN-6; LEUKOPLAKIA, ORAL; MALE; MIDDLE AGED; PERIODONTAL INDEX; PERIODONTITIS; PRECANCEROUS CONDITIONS; SALIVA; SALIVARY PROTEINS AND PEPTIDES; SMOKING; TOBACCO; TOBACCO, SMOKELESS; TUMOR MARKERS, BIOLOGICAL;

EID: 80052660318     PISSN: 14326981     EISSN: 14363771     Source Type: Journal    
DOI: 10.1007/s00784-010-0435-5     Document Type: Article

References (53)

1. Amarasinghe HK, Usgodaarachchi US, Johnson NW, Lalloo R, Warnakulasuriya S (2010) Betel-quid chewing with or without tobacco is a major risk factor for oral potentially malignant disorders in Sri Lanka: a case-control study. Oral Oncol 46: 297-301.
2. Harris CK, Warnakulasuriya KA, Cooper DJ, Peters TJ, Gelbier S (2004) Prevalence of oral mucosal lesions in alcohol misusers in south London. J Oral Pathol Med 33: 253-259.
3. Scully C, Field JK, Tanzawa H (2000) Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol 36: 256-263.
4. Day GL, Blot WJ, Austin DF, Bernstein L, Greenberg RS, Preston-Martin S, Schoenberg JB, Winn DM, McLaughlin JK, Fraumeni JF Jr (1993) Racial differences in risk of oral and pharyngeal cancer: alcohol, tobacco, and other determinants. J Natl Cancer Inst 85: 465.
5. Warnakulasuriya S, Johnson NW, van der Waal I (2007) Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 36: 575-580.
6. Banoczy J, Csiba A (1976) Occurrence of epithelial dysplasia in oral leukoplakia. Oral Surg Oral Med Oral Pathol 42: 766-774.
7. Gupta PC, Mehta FS, Daftary DK, Pindborg JJ, Bhonsle RB, Jalnawalla PN, Sinor PN, Pitkar VK, Murti PR, Irani RR, Shah HT, Kadam PM, Iyer KS, Iyer HM, Hegde AK, Chandrashekar GK, Shiroff BC, Sahiar BE, Mehta MN (1980) Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow-up study of Indian villagers. Community Dent Oral Epidemiol 8: 283-333.
8. Silverman S Jr, Gorsky M, Lozada F (1984) Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer 53: 563-568.
9. De Schutter H, Landuyt W, Verbeken E, Goethals L, Hermans R, Nuyts S (2005) The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy ± chemotherapy. BMC Cancer 5: 42.
10. Lumerman H, Freedman P, Kerpel S (1995) Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 79: 321-329.
11. World Health Organization (1997) Oral health surveys. Basic methods. World Health Organization, Geneva.
12. Brailo V, Vucićević-Boras V, Cekić-Arambasin A, Alajbeg IZ, Milenović A, Lukac J (2006) The significance of salivary interleukin 6 and tumor necrosis factor alpha in patients with oral leukoplakia. Oral Oncol 42: 370-373.
13. Navazesh M, Kumar SK, University of Southern California School of Dentistry (2008) Measuring salivary flow: challenges and opportunities. J Am Dent Assoc 139(Suppl): 35S-40S.
14. Ng PY, Donley M, Hausmann E, Hutson AD, Rossomando EF, Scannapieco FA (2007) Candidate salivary biomarkers associated with alveolar bone loss: cross-sectional and in vitro studies. FEMS Immunol Med Microbiol 49: 252-260.
15. Ferguson DB (1987) Current diagnostic uses of saliva. J Dent Res 66: 420-424.
16. Streckfus CF, Bigler LR (2002) Saliva as a diagnostic fluid. Oral Dis 8: 69-76.
17. Zimmermann BG, Wong DT (2008) Salivary mRNA targets for cancer diagnostics. Oral Oncol 44: 425-429.
18. Wang PL, Ohura K, Fujii T, Oido-Mori M, Kowashi Y, Kikuchi M, Suetsugu Y, Tanaka J (2003) DNA microarray analysis of human gingival fibroblasts from healthy and inflammatory gingival tissues. Biochem Biophys Res Commun 305: 970-973.
19. Liao WC, Lin JT, Wu CY, Huang SP, Lin MT, Wu AS, Huang YJ, Wu MS (2008) Serum interleukin-6 level but not genotype predicts survival after resection in stages II and III gastric carcinoma. Clin Cancer Res 14: 428-434.
20. Bigbee WL, Grandis JR, Siegfried JM (2007) Multiple cytokine and growth factor serum biomarkers predict therapeutic response and survival in advanced-stage head and neck cancer patients. Clin Cancer Res 13: 3107-3108.
21. Rhodus NL, Ho V, Miller CS, Myers S, Ondrey F (2005) NF-kappa B dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma. Cancer Detect Prev 29: 42-45.
22. St John MA, Li Y, Zhou X, Denny P, Ho CM, Montemagno C, Shi W, Qi F, Wu B, Sinha U, Jordan R, Wolinsky L, Park NH, Liu H, Abemayor E, Wong DT (2004) Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 130: 929-935.
23. Chang MC, Wu HL, Lee JJ, Lee PH, Chang HH, Hahn LJ, Lin BR, Chen YJ, Jeng JH (2004) The induction of prostaglandin E2 production, interleukin-6 production, cell cycle arrest, and cytotoxicity in primary oral keratinocytes and KB cancer cells by areca nut ingredients is differentially regulated by MEK/ERK activation. J Biol Chem 279: 50676-50683.
24. Johnson GK, Poore TK, Squier CA, Wertz PW, Reinhardt RA, Vincent SD (1994) Prostaglandin E2 and interleukin 1 levels in smokeless tobacco-induced oral mucosal lesions. J Periodontal Res 29: 430-438.
25. Jablonska E, Piotrowski L, Grabowska Z (1997) Serum levels of IL-1β, IL-6, TNF-α, TNF-R1 and CRP in patients with oral cavity cancer. Pathol Oncol Res 3: 126-129.
26. Nakano Y, Kobayashi W, Sugai S, Kimura H, Yagihashi S (1999) Expression of tumor necrosis factor-α and interleukin 6 in oral squamous cell carcinoma. Jpn J Cancer Res 90: 858-866.
27. Schafer ZT, Brugge JS (2007) IL-6 involvement in epithelial cancers. J Clin Invest 117: 3660-3663.
28. Hong DS, Angelo LS, Kurzrock R (2007) Interleukin-6 and its receptor in cancer: implications for translational therapeutics. Cancer 110: 1911-1928.
29. Sansone P, Storci G, Tavolari S, Guarnieri T, Giovannini C, Taffurelli M, Ceccarelli C, Santini D, Paterini P, Marcu KB, Chieco P, Bonafè M (2007) IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J Clin Invest 117: 3988-4002.
30. Wu HT, Ko SY, Fong JH, Chang KW, Liu TY, Kao SY (2009) Expression of phosphorylated Akt in oral carcinogenesis and its induction by nicotine and alkaline stimulation. J Oral Pathol Med 38: 206-213.
31. Søland TM, Husvik C, Koppang HS, Boysen M, Sandvik L, Clausen OP, Christoffersen T, Bryne M (2008) A study of phosphorylated ERK1/2 and COX-2 in early stage (T1-T2) oral squamous cell carcinomas. J Oral Pathol Med 37: 535-542.
32. Muraoka K, Shimizu K, Sun X, Zhang YK, Tani T, Hashimoto T, Yagi M, Miyazaki I, Yamamoto K (1997) Hypoxia, but not reoxygenation, induces interleukin 6 gene expression through NF-kappa B activation. Transplantation 63: 466-470.
33. Powis G, Kirkpatrick L (2004) Hypoxia inducible factor-1alpha as a cancer drug target. Mol Cancer Ther 3: 647-654.
34. Niu G, Briggs J, Deng J, Ma Y, Lee H, Kortylewski M, Kujawski M, Kay H, Cress WD, Jove R, Yu H (2008) Signal transducer and activator of transcription 3 is required for hypoxia-inducible factor-1alpha RNA expression in both tumor cells and tumor-associated myeloid cells. Mol Cancer Res 6: 1099-1105.
35. Shirogane T, Fukada T, Muller JM, Shima DT, Hibi M, Hirano T (1999) Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis. Immunity 11: 709-719.
36. Hirano T, Ishihara K, Hibi M (2000) Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 19: 2548-2556.
37. Barton BE, Murphy TF, Adem P, Watson RA, Irwin RJ, Huang HF (2001) IL-6 signalling by STAT3 participates in the change from hyperplasia to neoplasia in NRP-152 and NRP-154 rat prostatic epithelial cells. BMC Cancer 1: 19.
38. Grivennikov S, Karin M (2008) Autocrine IL-6 signaling: a key event in tumorigenesis? Cancer Cell 13: 7-9.
39. Gao SP, Mark KG, Leslie K, Pao W, Motoi N, Gerald WL, Travis WD, Bornmann W, Veach D, Clarkson B, Bromberg JF (2007) Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. J Clin Invest 117: 3846-3856.
40. Sriuranpong V, Park JI, Amornphimoltham P, Patel V, Nelkin BD, Gutkind JS (2003) Epidermal growth factor receptor-independent constitutive activation of STAT3 in head and neck squamous cell carcinoma is mediated by the autocrine/paracrine stimulation of the interleukin 6/gp130 cytokine system. Cancer Res 63: 2948-2956.
41. Hodge DR, Peng B, Cherry JC, Hurt EM, Fox SD, Kelley JA, Munroe DJ, Farrar WL (2005) Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation. Cancer Res 65: 4673-4682.
42. Resnitzky D, Tiefenbrun N, Berissi H, Kimchi A (1992) Interferons and interleukin-6 suppress phosphorylation of the retinoblastoma protein in growth-sensitive hematopoietic cells. Proc Natl Acad Sci U S A 89: 402-406.
43. Santhanam U, Ray A, Sehgal PB (1991) Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product. Proc Natl Acad Sci U S A 88: 7605-7609.
44. Angelo LS, Talpaz M, Kurzrock R (2002) Autocrine interleukin-6 production in renal cell carcinoma: evidence for the involvement of p53. Cancer Res 62: 932-940.
45. Conze D, Weiss L, Regen PS, Bhushan A, Weaver D, Johnson P, Rincón M (2001) Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells. Cancer Res 61: 8851-8858.
46. Beklen A, Hukkanen M, Richardson R, Konttinen YT (2008) Immunohistochemical localization of Toll-like receptors 1-10 in periodontitis. Oral Microbiol Immunol 23: 425-431.
47. Hong SH, Ondrey FG, Avis IM, Chen Z, Loukinova E, Cavanaugh PF Jr, van Waes C, Mulshine JL (2000) Cyclooxygenase regulates human oropharyngeal carcinomas via the proinflammatory cytokine IL-6: a general role for inflammation? FASEB J 14: 1499-1507.
48. Tezal M, Sullivan MA, Reid ME, Marshall JR, Hyland A, Loree T, Lillis C, Hauck L, Wactawski-Wende J, Scannapieco FA (2007) Chronic periodontitis and the risk of tongue cancer. Arch Otolaryngol Head Neck Surg 133: 450-454.
49. Tezal M, Sullivan MA, Hyland A, Marshall JR, Stoler D, Reid ME, Loree TR, Rigual NR, Merzianu M, Hauck L, Lillis C, Wactawski-Wende J, Scannapieco FA (2009) Chronic periodontitis and the incidence of head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 18: 2406-2412.
50. Zhang J, Liu Y, Shi J, Larson DF, Watson RR (2002) Side stream cigarette smoke induces dose response in systemic inflammatory cytokine production and oxidative stress. Exp Biol Med (Maywood) 227: 823-829.
51. Erdemir EO, Duran I, Haliloglu S (2004) Effects of smoking on clinical parameters and the gingival crevicular fluid levels of IL-6 and TNF-α in patients with chronic periodontitis. J Clin Periodontol 31: 99-104.
52. Jeng JH, Wang YJ, Chiang BL, Lee PH, Chan CP, Ho YS, Wang TM, Lee JJ, Hahn LJ, Chang MC (2003) Roles of keratinocyte inflammation in oral cancer: regulating the prostaglandin E2, interleukin-6 and TNF-alpha production of oral epithelial cells by areca nut extract and arecoline. Carcinogenesis 24: 1301-1315.
53. Wendell KJ, Stein SH (2001) Regulation of cytokine production in human gingival fibroblasts following treatment with nicotine and lipopolysaccharide. J Periodontol 72: 1038-1044.